Sun Pharmaceutical Industries is addressing regulatory issues at three facilities, including an import alert at Halol.

Sun Pharma is stepping up regulatory compliance efforts at three USFDA-flagged facilities, including Halol, Mohali, and Dadra.

Sun Pharma aims to enhance compliance and R&D investment for global speciality products, targeting mid to high single-digit ...

Sun Pharma is working to resolve USFDA compliance issues at three facilities: Halol, Mohali, and Dadra. The company is implementing CAPA and anticipates mid to high single-digit growth in FY26.

Mumbai: Sun Pharma Advanced Research Company Limited (SPARC) has announced the incorporation of its wholly owned subsidiary, ...

N ew Delhi: Sun Pharma and Zydus Pharmaceuticals are recalling products in the US market due to manufacturing issues, according to the US Food and Drug Administration (USFDA). The New Jersey-based ...

Sun Pharmaceutical Industries has created a U.S. website for its long-term care (LTC) division. The site pulls together products aimed at the 40% of American adults estimated to have trouble ...

Only two Sun Pharma products are identified in the US FDA's letter: medroxyprogesterone acetate and testosterone cypionate. Inspectors flagged other medicines of concern but the names have been ...

Sun Pharmaceutical Industries posted a nearly 2% fall in first-quarter profit on Thursday as higher expenses offset demand for its drugs and related products. Skip to main content ...

Pharma major Sun Pharmaceutical Industries Ltd has said it filed Abbreviated New Drug Applications for four products and received nine approvals from the US FDA in the first quarter this fiscal.

Two Indian manufacturers of generic drugs—Sun Pharma and Glenmark—landed on the FDA’s weekly enforcement report for recalls in the United States. On June 21, Sun Pharma initiated a voluntary ...

NEW DELHI: Drug makers Glenmark, Sun Pharma and Zydus are recalling products in the US for manufacturing issues, the US Food and Drug Administration (USFDA) said in its latest Enforcement Report.